|
Volumn 9, Issue 3, 1977, Pages 277-288
|
Current status of the therapy of advanced renal carcinoma
|
Author keywords
chemotherapy; hormonal therapy; immunotherapy; metastatic cancer; renal carcinoma; renal tumor model systems; vinblastine
|
Indexed keywords
6 AMINONICOTINAMIDE;
ALTRETAMINE;
AZACITIDINE;
BLEOMYCIN;
CARMUSTINE;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DACARBAZINE;
DACTINOMYCIN;
DIANHYDROGALACTITOL;
DOXORUBICIN;
ETOPOSIDE;
FLOXURIDINE;
FLUOROURACIL;
HYDROXYUREA;
LOMUSTINE;
MEDROXYPROGESTERONE ACETATE;
MERCAPTOPURINE;
METHOTREXATE;
MITOMYCIN C;
PREDNISONE;
PYRAZOLOPYRIMIDINE DERIVATIVE;
SEMUSTINE;
THIOTEPA;
VINBLASTINE;
VINCRISTINE;
1 PYRAZOLETHIOCARBOXAMIDE;
AZATEPA;
BENZODEPA;
CANCER;
CANCER CHEMOTHERAPY;
DRUG THERAPY;
HADACIN;
IMMUNOTHERAPY;
KIDNEY CARCINOMA;
METASTASIS;
METUREDEPA;
MOBECARB;
THERAPY;
ADENOCARCINOMA;
ANDROGENS;
ANIMAL;
ANTINEOPLASTIC AGENTS;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMAN;
IMMUNOTHERAPY;
KIDNEY NEOPLASMS;
LOMUSTINE;
MALE;
MICE;
MICE, INBRED BALB C;
NEOPLASM REGRESSION, SPONTANEOUS;
NEOPLASMS, EXPERIMENTAL;
PROGESTATIONAL HORMONES;
REMISSION, SPONTANEOUS;
SEMUSTINE;
SUPPORT, U.S. GOV'T, P.H.S.;
VINBLASTINE;
|
EID: 0017656264
PISSN: 00224790
EISSN: 10969098
Source Type: Journal
DOI: 10.1002/jso.2930090310 Document Type: Article |
Times cited : (145)
|
References (34)
|